INDIVIDUALIZED GENETIC MAKEUP THAT CONTROLS NATURAL KILLER CELL FUNCTION INFLUENCES THE EFFICACY OF ISATUXIMAB IMMUNOTHERAPY IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
作者：
Rajalingam, R. [1 ]
Sun, H. [1 ]
Kong, D. [1 ]
Mace, S. [2 ]
Chiron, M. [2 ]
机构：
[1] Univ Calif San Francisco, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA
[2] Sanofi Res & Dev, Translat & Expt Med, Cambridge, MA USA
来源：
HUMAN IMMUNOLOGY | 2021年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P49
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
[21]   Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma [J].
Kim, Sojeong ;
Chung, Haerim ;
Kwak, Jeong-Eun ;
Kim, Yu Ri ;
Park, Chung Hyun ;
Kim, Yeonhee ;
Cheong, June-Won ;
Wu, Jennifer ;
Shin, Eui-Cheol ;
Cho, Hyunsoo ;
Kim, Jin Seok .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
[22]   INVESTIGATION OF NATURAL KILLER CELL FUNCTION AND PHENOTYPES IN STABLE AND ACTIVE MULTIPLE SCLEROSIS PATIENTS [J].
Khalilidehkordi, Elham ;
Cabanas, Helene ;
Eaton, Natalie ;
Broadley, Simon ;
Balinas, Cassandra ;
Du Preez, Stanley ;
Maksoud, Rebekah ;
Staines, Donald ;
Marshall-Gradisnik, Sonya .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06) :E43-E43
[23]   Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy [J].
Song, Weihua ;
van der Vliet, Hans J. J. ;
Tai, Yu-Tzu ;
Prabhala, Rao ;
Wang, Ruojie ;
Podar, Klaus ;
Catley, Laurence ;
Shammas, Masood A. ;
Anderson, Kenneth C. ;
Balk, Steven P. ;
Exley, Mark A. ;
Munshi, Nikhil C. .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6955-6962
[24]   Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer [J].
Yong-Hee Cho ;
Myeong Geun Choi ;
Dong Ha Kim ;
Yun Jung Choi ;
Seon Ye Kim ;
Ki Jung Sung ;
Jae Cheol Lee ;
Sang-Yeob Kim ;
Jin Kyung Rho ;
Chang-Min Choi .
Targeted Oncology, 2020, 15 :241-247
[25]   Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer [J].
Cho, Yong-Hee ;
Choi, Myeong Geun ;
Kim, Dong Ha ;
Choi, Yun Jung ;
Kim, Seon Ye ;
Sung, Ki Jung ;
Lee, Jae Cheol ;
Kim, Sang-Yeob ;
Rho, Jin Kyung ;
Choi, Chang-Min .
TARGETED ONCOLOGY, 2020, 15 (02) :241-247
[26]   Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study [J].
Zhao, Jing ;
Wang, Xiaoning ;
Zhu, Huachao ;
Wei, Suhua ;
Zhang, Hailing ;
Ma, Le ;
Zhu, Wenjuan .
CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
[27]   Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation [J].
Ocio, Enrique M. ;
Perrot, Aurore ;
Bories, Pierre ;
San-Miguel, Jesus F. ;
Blau, Igor W. ;
Karlin, Lionel ;
Martinez-Lopez, Joaquin ;
Wang, Song-Yau ;
Bringhen, Sara ;
Marcatti, Magda ;
Mateos, Maria-Victoria ;
Rodriguez-Otero, Paula ;
Oliva, Stefania ;
Nogai, Axel ;
Le Roux, Nadia ;
Dong, Liyan ;
Mace, Sandrine ;
Gassiot, Matthieu ;
Fitzmaurice, Thomas ;
Oprea, Corina ;
Moreau, Philippe .
LEUKEMIA, 2023, 37 (07) :1521-1529
[28]   Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation [J].
Enrique M. Ocio ;
Aurore Perrot ;
Pierre Bories ;
Jesus F. San-Miguel ;
Igor W. Blau ;
Lionel Karlin ;
Joaquin Martinez-Lopez ;
Song-Yau Wang ;
Sara Bringhen ;
Magda Marcatti ;
María-Victoria Mateos ;
Paula Rodriguez-Otero ;
Stefania Oliva ;
Axel Nogai ;
Nadia Le Roux ;
Liyan Dong ;
Sandrine Macé ;
Matthieu Gassiot ;
Thomas Fitzmaurice ;
Corina Oprea ;
Philippe Moreau .
Leukemia, 2023, 37 :1521-1529
[29]   Restoration of NK cell function against multiple myeloma cells by an adjunctive effect of activated invariant natural killer T (NKT) cells [J].
Iyoda, Tomonori ;
Yamasaki, Satoru ;
Hidaka, Michihiro ;
Kawano, Fumio ;
Abe, Yu ;
Suzuki, Kenshi ;
Kadowaki, Norimitsu ;
Shimizu, Kanako ;
Fujii, Shin-ichiro .
CYTOKINE, 2017, 100 :128-129
[30]   One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy [J].
Besson, Laurie ;
Charrier, Emily ;
Karlin, Lionel ;
Allatif, Omran ;
Marcais, Antoine ;
Rouzaire, Paul ;
Belmont, Lucie ;
Attal, Michel ;
Lombard, Christine ;
Salles, Gilles ;
Walzer, Thierry ;
Viel, Sebastien .
FRONTIERS IN IMMUNOLOGY, 2018, 9
12345